QPS provides drug development services through facilities in North America, Europe, and Asia, supporting studies from discovery through clinical research. Its capabilities include DMPK, toxicology, bioanalysis, translational medicine, early-phase clinical trials, and clinical research services across multiple therapeutic areas. Global laboratory and operational infrastructure allows sponsors to coordinate complex programs while accessing regional expertise, participant populations, and regulatory experience.
QPS
QPS is a leading, GLP/GCP-compliant contract research organization (CRO) offering comprehensive preclinical and clinical drug development services across toxicology, DMPK, and bioanalysis. Operating global facilities, QPS supports pharmaceutical and biotech sponsors from initial IND-enabling studies through all phases of clinical trials with rigorous bioanalytical validation.
